DVA
62
5
ZION
49
9
AMP
43
2
PEG
53
7
RF
44
10
HAL
40
11
MS
64
3
LOW
42
14
MHK
25
5
AES
47
4
T
32
2
MTCH
62
22
EXPE
83
8
PX
56
3
NSC
33
6
AAPL
64
3
ESS
44
5
R
55
-2
ILMN
31
4
BAX
38
2
DVA
62
5
ZION
49
9
AMP
43
2
PEG
53
7
RF
44
10
HAL
40
11
MS
64
3
LOW
42
14
MHK
25
5
AES
47
4
T
32
2
MTCH
62
22
EXPE
83
8
PX
56
3
NSC
33
6
AAPL
64
3
ESS
44
5
R
55
-2
ILMN
31
4
BAX
38
2
Financhill
Back

CNS Pharmaceuticals 10K Form

Sell
36

CNSP
CNS Pharmaceuticals

Last Price:
$0.11
Seasonality Move:
-46.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CNSP News And Ratings

See the #1 stock for the next 7 days that we like better than CNSP

CNSP Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-6.8M
Price / Cash Flow: 0
Annual Sales: $0.10
Price / Book: 1.9

Profitability

EPS (TTM): -70.71730
Net Income (TTM): $-17.1M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

CNS Pharmaceuticals Earnings Forecast

Key CNS Pharmaceuticals Financial Ratios

  • The Interest Expense is -0.07% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 4 years.

CNS Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CNSP
Website: cnspharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CNSP Technical Analysis vs Fundamental Analysis

Sell
36
CNS Pharmaceuticals (CNSP) is a Sell

Is CNS Pharmaceuticals a Buy or a Sell?